Merz Korea signs business agreement of ‘Contractubex’ with C&C Healthcare
Follow by the business agreement for ‘Pantogar’ last March, Merz Korea is newly launching an OTC drug business by selecting a new partner for ‘Contractubex,’ a scar treatment.
Merz Korea(CEO Soo-Yeon Yoo), a German pharmaceutical company specializing in aesthetics, signed an business agreement f...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
